beta
/QRL-201-01: A multi-center, randomized, double-blind, placebo-controlled multiple ascending dose study to evaluate the safety and tolerability of QRL-201 in amyotrophic lateral sclerosis
Abstract

Abstract N/A

RelatedView All
Authors 10View All
CitationsView All
Citing-
Cited By-